REGENERON PHARMACEUTICALS INC (REGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for REGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| REGN | Director | 71 | ["Professor in the Departments of Pediatrics, Molecular and Human Genetics, and Neurology and Neuroscience at Baylor College of Medicine since 1994","Director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital","Howard Hughes Medical Institute Investigator","Breakthrough Prize in Life Sciences","Pearl Meister Greengard Prize","March of Dimes Prize in Developmental Biology","Vanderbilt Prize in Biomedical Science"] | ["Compensation Committee","Technology Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Age: 71 Director since: 2016 Board and Committee Membership 2025 Attendance Board of Directors: 14/15 Compensation Committee: 10/11 Technology Committee: 2/2 Career Highlights Professor in the Departments of Pediatrics, Molecular and Human Genetics, and Neurology and Neuroscience at Baylor College of Medicine since 1994 Director of the Jan and Dan Duncan Neurological Research Institute at Texas Children s Hospital Howard Hughes Medical Institute Investigator Breakthrough Prize in Life Sciences Pearl Meister Greengard Prize March of Dimes Prize in Developmental Biology Vanderbilt Prize in Biomedical Science Experience and Expertise Executive/Leadership Experience Science/Biotech Background Research/Academic Experience Scientific Society Memberships The National Academy of Sciences The Institute of Medicine The American Association for the Advancement of Science Reason for Nomination Dr. Zoghbi s extensive research experience and her scientific and academic career and accomplishments led the board s decision to nominate Dr. Zoghbi for reelection to the board.